But now the FDA has rubber-stamped the approval of Luxturna, the first ever gene therapy it has backed, all the attention is now on Spark, and what price it plans to charge for the therapy.
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.
along with the dog's medical history, "how many times the dog has received Librela, and the lot number on the vial used." Drug sponsors are required to inform the FDA of any reports of adverse ...